Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for IFF

Update shared on 01 Nov 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-31.2%
7D
1.1%

International Flavors & Fragrances has seen its average analyst price target revised downward by several dollars as analysts cite continued weakness in end market demand, macroeconomic headwinds, and a lack of near-term catalysts for upside in the shares.

Analyst Commentary

Recent Street research has reflected a mix of cautious outlooks and selective optimism toward International Flavors & Fragrances, as analysts adjust their views in light of near-term challenges and sector dynamics.

Bullish Takeaways
  • Bullish analysts point to the company's ongoing recovery strategy under new leadership. Expectations are that operational improvements could drive future results.
  • Some upgrades acknowledge that several long-term risks are now better understood and priced in. This leads to a more balanced risk/reward profile for the shares.
  • The constructive stance is maintained on the potential for a positive inflection in earnings estimates, which could act as a catalyst for share price appreciation.
Bearish Takeaways
  • Bearish analysts highlight persistent macroeconomic headwinds, including inconsistent demand in end markets and recent slippage in commodity-related businesses.
  • Several price targets have been lowered due to muted near-term catalysts. Seasonality and market conditions are providing little support for valuation upside.
  • Concerns linger regarding prolonged headwinds in the Health segment. These are now expected to impact financial performance into 2026.
  • Reduced estimates and valuation compression among peers are seen as limiting near-term growth potential. Many view the shares as fairly valued given current risks.

What's in the News

  • IFF announced a strategic collaboration with BASF to advance Designed Enzymatic Biomaterials™ technology, focusing on innovative, sustainable solutions for personal care, cleaning, and industrial applications (Client Announcements).
  • The company plans to build a new scent creative center in Mumbai, India, set to open by mid-2026. This will increase IFF’s presence and innovation capabilities in a key growth market (Business Expansions).
  • IFF’s LMR Naturals site in Grasse has completed a major expansion and increased its capacity for natural ingredient development and research by 75% (Business Expansions).
  • The unveiling of SipScape, a new platform targeting the adult beverage sector, highlights IFF’s approach to flavor innovation, consumer trends, and conscious consumption (Product-Related Announcements).
  • IFF launched the POWERFRESH® ACE 2000 enzyme solution in the U.S., designed to help bakeries extend bread freshness and reduce waste (Product-Related Announcements).

Valuation Changes

  • The discount rate has decreased slightly, moving from 8.16% to 8.15%.
  • Revenue growth expectations have shifted from positive 2.7% to negative 1.0%, reflecting a notable decline in growth assumptions.
  • The net profit margin has edged down from 7.33% to 7.06%.
  • The future P/E ratio has increased from 32.3x to 33.5x, indicating a higher valuation multiple on expected earnings.
  • The fair value estimate remains unchanged at $81.96.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.